Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In vitro and in vivo activities of LCB01-0371
A novel small-molecule inhibitor of NF-kappaB signaling
potent and selective prostanoid EP4 receptor antagonist
24(3):401-11
double-blind
SMI-4a - CAS# 438190-29-5 0256 In vitro and in vivoSMI 4a, CAS No. 438190 29 5, is a potent and selective Pim protein kinase inhibitor, which blocks the growth of precursor T cell lymphoblastic leukemia lymphoma. SMI 4a was found to induce phosphorylation of extracellular signal related kinase1 2 (ERK1 2), and the combination of SMI 4a and a mitogen activated protein kinase kinase 1 2 (MEK1 2) inhibitor was highly synergistic in killing pre T LBL cells. SMI 4a may be developed as a therapeutic
US$ 325.00
US$ 300.00
US$ 78.34
US$ 190.00
US$ 187.50
US$ 270.00
US$ 297.50
US$ 80.00
US$ 1500.00